Drug Database
Back to search

Netherlands· NL-ead9cdea0cbb

Typhim Vi, oplossing voor injectie 0,025 mg/0,5 ml

A typhus, gereinigtes polysaccharid-antigen product containing salmonella typhusstam typhustaxcapsulair polyoxide vi, registered in Netherlands by Medcor Pharmaceuticals B.V.. The same ATC class is registered in 9 of our 19 countries.

ATC J07AP03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedTyphim Vi, oplossing voor injectie 0,…ATCJ07AP03REGISTER NO.NL-ead9cdea0cbbPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about salmonella typhusstam typhustaxcapsulair polyoxide viAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Typhus, gereinigtes polysaccharid-antigen is registered in 9 of 19 countries.

Countries holding a registration under ATC J07AP03 (typhus, gereinigtes polysaccharid-antigen), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose
Search typhus, gereinigtes polysaccharid-antigen products by name

Typhus, gereinigtes polysaccharid-antigen · ATC J07AP03

9 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
SALMONELLA TYPHUSSTAM TYPHUSTAXCAPSULAIR POLYOXIDE VI
Manufacturer
Medcor Pharmaceuticals B.V.
Country
Netherlands (NL)
ATC code
J07AP03
ATC class
Typhus, gereinigtes Polysaccharid-Antigen
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    134027//17568

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J07AP03

Typhus, gereinigtes polysaccharid-antigen, as other registers publish it.

All typhus, gereinigtes polysaccharid-antigen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fd601c37-4688-44cb-b2b4-c3e726dd0533
GET /v1/drugs/fd601c37-4688-44cb-b2b4-c3e726dd0533?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intramusculair gebruik, Subcutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h17568_smpc.pdf",
  "strength": null,
  "atc_label": "Typhoid, Purified Polysaccharide Antigen",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg134027",
  "excipients": [
    "DINATRIUMWATERSTOFFOSFAAT 2-WATER (E 339)",
    "FENOL",
    "NATRIUMCHLORIDE",
    "NATRIUMDIWATERSTOFFOSFAAT 2-WATER (E 339)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "SALMONELLA TYPHUSSTAM TYPHUSTAXCAPSULAIR POLYOXIDE VI"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h134027.pdf",
  "authorised_at": "2024/12/11",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "134027//17568",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about typhus, gereinigtes polysaccharid-antigen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console